Show Summary Details
Page of

Common problems in lipid management 

Common problems in lipid management
Common problems in lipid management

John Reckless

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 October 2018

Cholesterol and low-density lipoprotein (LDL)-cholesterol are causal factors for atheromatous cardiovascular disease (CVD), and moderate and higher levels are a near obligate for disease development.

Statin drugs have overwhelming evidence of benefit at low side effect risk.

Estimation of an individual's CVD risk is required from a number of factors, and CVD prevention requires attention to all abnormal modifiable factors in individuals at higher risk.

Identifying, counselling, and appropriate treatment of individuals at high CVD risk is a current challenge for health care professionals.

Guidelines have been produced to help, and Government has provided levers to encourage their application.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.